Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy-Reference-Cited by-同舟云学术

Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy

Published:2020-10-23 Issue:43 Volume:99 Page:e22351
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Ocasio-Rivera Marinel,Marin-Maldonado Frances,Trossi-Torres Geraline,Ortiz-Rosado Angely,Rodríguez-Irizarry Valerie,Rodriguez-Lopez Eric,Martínez Sahayra,Almodóvar Sharilyn,Suarez-Martínez Edu

Funder

National Institute of General Medical Sciences

Puerto Rico Science, Technology and Research Trust

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference25 articles.

1. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma;Burchard;Am J Respir Crit Care Med,2004

2. An estimate of the prevalence, severity and seasonality of asthma in visitors to a Ponce shopping center;Montealegre;P R Health Sci J,1996

3. Expression of and functional responses to protease-activated receptors on human eosinophils;Bolton;J Leukoc Biol,2003

4. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2;Uehara;J Immunol,2003

5. Human bronchial epithelial cells express PAR-2 with different sensitivity to thermolysin;Ubl;Am J Physiol Lung Cell Mol Physiol,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protease-Activated Receptor 2 in inflammatory skin disease: current evidence and future perspectives;Frontiers in Immunology;2024-09-05

2. FSLLRY-NH2, a protease-activated receptor 2 (PAR2) antagonist, activates mas-related G protein-coupled receptor C11 (MrgprC11) to induce scratching behaviors in mice;Life Sciences;2023-07

3. PAR2: The Cornerstone of Pancreatic Diseases;Physiological Research;2022-10-31

4. The immune response to airway mycosis;Current Opinion in Microbiology;2021-08